To Inject or Not to Inject? Corticosteroid Injections in the Face of the COVID-19 Pandemic
Abstract
Corticosteroid injections (CSI), a recognized modality of treatment in patients with musculoskeletal conditions, is under controversy post WHO advice against the therapeutic use of systemic corticosteroids for COVID- 19 patients. In our opinion unless CSI is proven harmful, withholding such treatment is not justified. An online survey amongst a significant number of rheumatologists in Pakistan was conducted to assess local practices and outcomes. 55 responses were recorded with 73.6% (n39) being from the province of Punjab. More than two thirds 69.8% (n37) of participants had administered a CSI during the pandemic, and only one patient developed COVID-19. It appears that most rheumatologists in Pakistan have not changed their practice with regards to the use of CSI. Following the recent recommendation of the use of dexamethasone for the treatment of COVID-19 we suggest the guidelines for CSI be revisited.
How to Cite This Article
Khan SEA, Ahmad NM, Farman S, Saeed MA, Amjad SMD, Tahir H. To Inject or Not to Inject? Corticosteroid Injections in the Face of the COVID-19 Pandemic. J Pak Soc Intern Med. 2021;2(1):65–67. doi:10.70302/jpsim.v2i1.2118
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. 2nd ed. [Updated 2020, cited 12 January 2021]. Available from: [https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf]
- Fitzpatrick J. NSAIDs and corticosteroid injections during the COVID pandemic: what Sport and Exercise Medicine Physicians (and sports physios) should know. BJSM Blog [Updated 2020, cited 12 January 2021]. Available from: [https://blogs.bmj.com/bjsm/2020/03/21/nsaids-and-corticosteroid-injections-during-the-covid-pandemic-what-sport-and-exercise-medicine-physicians-and-sports-physios-should-know/]
- Association of Chartered Physiotherapists in Orthopaedic Medicine & Injection Therapy. COVID-19 & injection therapy. Association of Chartered Physiotherapists in Orthopaedic Medicine & Injection Therapy. 2020 [Updated 2020, cited January 2021]. Available from: [https://acpomit.csp.org.uk/content/covid-19-injection-therapy]
- Stout A, Friedly J, Standaert C. Systemic Absorption and Side Effects of Locally Injected Glucocorticoids. PM&R. 2019;11(4):409-19.
- Little C, Birks M, Horwitz M, Ng C, Warwick D. COVID-19: A rethink of corticosteroid injection? Bone Joint Open. 2020;1(6):253-6.
- Arabi Y, Mandourah Y, Al-Hameed F, Sindi A, Almekhlafi G, Hussein M et al. Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome. Am J Resp Crit Care Med. 2018;197(6):757-67.
- D’Antiga L. Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic. Liver Transplant. 2020;26(6):832-4.
- Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Int Med. 2020;180(7):934.
- Rezaie S. The RECOVERY Trial: Dexamethasone for COVID-19? - REBEL EM - Emergency Medicine Blog. [Updated 2020, cited January 2021]. Available from: [https://rebelem.com/the-recovery-trial-dexamethasone-for-covid-19/]
- Mikuls T, Johnson S, Fraenkel L, Arasaratnam R, Baden L, Bermas B et al. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1. Arthritis & Rheumatology. [Updated 2020, cited January 2021]. Available from: [https://onlinelibrary.wiley.com/doi/full/10.1002/art.41301] doi:10.1002/art.41301]
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.